Molecularly targeted therapy in neuro-oncology

by Sith Sathornsumetee, Jeremy N. Rich
Published 2018

Antiangiogenic therapy in malignant glioma: Promise and challenge

by Sith Sathornsumetee, Jeremy N. Rich
Published 2018

Designer therapies for glioblastoma multiforme

by Sith Sathornsumetee, Jeremy N. Rich
Published 2018

Diagnosis and Treatment of High-Grade Astrocytoma

by Sith Sathornsumetee, Jeremy N. Rich, David A. Reardon
Published 2018

Medical oncology: Treatment and management of malignant gliomas

by Deric M. Park, Sith Sathornsumetee, Jeremy N. Rich
Published 2018

Twisted tango: Brain tumor neurovascular interactions

by Anita B. Hjelmeland, Justin D. Lathia, Sith Sathornsumetee, Jeremy N. Rich
Published 2018

Phase i study of sunitinib and irinotecan for patients with recurrent malignant glioma

by David A. Reardon, James J. Vredenburgh, April Coan, Annick Desjardins, Katherine B. Peters, Sridharan Gururangan, Sith Sathornsumetee, Jeremy N. Rich, James E. Herndon, Henry S. Friedman
Published 2018

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

by David A. Reardon, James E. Herndon, Katherine Peters, Annick Desjardins, April Coan, Emil Lou, Ashley Sumrall, Scott Turner, Sith Sathornsumetee, Jeremy N. Rich, Susan Boulton, Eric S. Lipp, Henry S. Friedman, James J. Vredenburgh
Published 2018

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma

by David A. Reardon, Annick Desjardins, James J. Vredenburgh, James E. Herndon, April Coan, Sridharan Gururangan, Katherine B. Peters, Roger McLendon, Sith Sathornsumetee, Jeremy N. Rich, Eric S. Lipp, Dorothea Janney, Henry S. Friedman
Published 2018

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

by Sith Sathornsumetee, Annick Desjardins, James J. Vredenburgh, Roger E. McLendon, Jennifer Marcello, James E. Herndon, Alyssa Mathe, Marta Hamilton, Jeremy N. Rich, Julie A. Norfleet, Sridharan Gururangan, Henry S. Friedman, David A. Reardon
Published 2018

Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma

by David A. Reardon, James J. Vredenburgh, Annick Desjardins, Katherine B. Peters, Sith Sathornsumetee, Stevie Threatt, John H. Sampson, James E. Herndon, April Coan, Frances McSherry, Jeremy N. Rich, Roger E. McLendon, Steven Zhang, Henry S. Friedman
Published 2018